Progressive Mould Intake Disease:
Is Your Air Conditioner Making You Chronically Sick?

There is a pattern emerging in respiratory medicine that every air conditioning technician on the Central Coast has seen firsthand: a family moves into a house, the air conditioner hasn't been cleaned in years, and within months, someone in that house develops a chronic cough that won't go away. It starts mild. Then it gets worse. Then it becomes permanent.

Doctors call it different things — allergic aspergillosis, hypersensitivity pneumonitis, chronic inflammatory response syndrome. But the mechanism is the same. And the source is often sitting on the wall, quietly circulating contaminated air through every room.

The Mechanism: How Mould In Your AC Reaches Your Lungs

To understand the disease, you have to understand the delivery system. A split system air conditioner is not just a cooling device — it is a closed-loop air circulation engine. It pulls air from your room, passes it over cold coils where condensation forms, and blows it back out. Every hour of operation, the entire volume of air in a typical bedroom passes through that unit 4-6 times.

Inside the unit, three things happen simultaneously:

1. Condensation creates a perpetually wet environment. The cooling coils produce water constantly during summer operation. The drain pan beneath collects this water. The internal surfaces stay damp for hours after the unit cycles off.
2. Organic dust accumulates. Skin cells, pet dander, pollen, and textile fibres from clothing and bedding are drawn in with the return air. This organic material settles on every internal surface and becomes a nutrient bed.
3. Darkness and warmth incubate growth. The internal cavity of a split system is dark, warm (when off), and humid — the exact conditions mould spores require to germinate and colonise.

The result: within 4-6 weeks of regular use, a clean split system develops visible mould colonies on the fan barrel, coil surfaces, and drain pan. Within 3 months, the colony is established enough to begin releasing spores into the airstream. Within 6-12 months, the unit becomes a biological aerosol generator — actively distributing mould spores, bacterial fragments, and mycotoxins into the breathing zone of the room.

The Disease Progression: Four Stages of Mould-Mediated Respiratory Decline

Medical literature and clinical observation describe a pattern of progressive respiratory illness associated with chronic mould exposure from contaminated indoor air systems. The condition does not appear overnight. It advances through recognisable stages.

Stage 1: Mucosal Irritation (Weeks 1-4 of Exposure)

The first response is the body's mechanical defence. Mould spores and fungal fragments contact the mucous membranes of the nose, throat, and upper airways. The body responds with inflammation.

• Symptoms: Persistent dry cough, throat clearing, nasal congestion, sneezing upon waking, itchy or watery eyes
• What's happening: Fungal cell wall components (beta-glucans) trigger innate immune receptors (dectin-1) on airway epithelial cells, causing localised inflammatory cytokine release
• Why it's missed: These symptoms are indistinguishable from a common cold or seasonal allergies. Most people treat it with antihistamines and move on
• Prognosis if exposure stops: Full recovery within days

Stage 2: Allergic Sensitisation (Months 1-6)

With continued exposure, the adaptive immune system begins to recognise specific mould proteins as threats. IgE antibodies are produced. Mast cells in the respiratory tract become primed to react. This is the same mechanism behind classic allergies — but unlike pollen, the antigen source is in your house 24 hours a day.

• Symptoms: Worsening cough, wheezing, chest tightness, shortness of breath on exertion, chronic sinus congestion, post-nasal drip, disturbed sleep from coughing
• What's happening: IgE-mediated mast cell degranulation in the bronchial mucosa. Eosinophil infiltration of airway tissues. Bronchial hyperresponsiveness develops — the airways begin to constrict in response to lower and lower concentrations of the trigger
• Common misdiagnosis: Adult-onset asthma, recurrent bronchitis, "that cough that won't go away"
• Prognosis if exposure stops: Gradual improvement over weeks to months. Some airway hyperresponsiveness may persist

Stage 3: Colonisation and Fungal Infection (Months 6-24)

This is where the condition becomes medically serious. In a subset of exposed individuals — particularly those with pre-existing lung architecture abnormalities, mild immune deficiency, or prolonged high-concentration exposure — the mould does not just trigger an allergic response. It begins to grow inside the airways.

• Condition: Allergic Bronchopulmonary Aspergillosis (ABPA) — most commonly caused by Aspergillus fumigatus, the same mould species found in 85% of contaminated air conditioners tested in clinical audits
• Symptoms: Productive cough with thick, brownish mucus plugs, haemoptysis (coughing blood), fever and night sweats, significant weight loss, fatigue, CT scan showing central bronchiectasis with "finger-in-glove" opacities
• What's happening: Aspergillus hyphae colonise the bronchial lumen. The immune system attacks the fungus but also damages the bronchial wall in the process. Over months, the airways become permanently dilated and scarred — bronchiectasis
• Why it's devastating: Bronchiectasis is irreversible. Once the airways are scarred and dilated, they cannot return to normal. The damage is permanent. Patients require lifelong management with inhaled corticosteroids, bronchodilators, and sometimes antifungal therapy. In severe cases, they need supplemental oxygen
• Prognosis if exposure stops: Any existing bronchiectasis is permanent. Further progression can be halted, but the damage already done does not heal

"A patient with ABPA from household mould exposure is one of the most tragic cases we see in respiratory medicine. By the time they reach us, the bronchiectasis is established. We can stop it getting worse — we cannot undo it." — Clinical observation from a respiratory physician, Royal Prince Alfred Hospital

Stage 4: Chronic Inflammatory Response Syndrome (Years of Exposure)

In patients with specific HLA gene variants (approximately 24% of the population), the body's ability to clear mould toxins is genetically impaired. Mycotoxins — toxic secondary metabolites produced by mould species including Stachybotrys chartarum (black mould) and various Aspergillus species — accumulate in tissues because the immune system cannot process and excrete them efficiently.

• Condition: Chronic Inflammatory Response Syndrome (CIRS), also known as mould biotoxin illness
• Symptoms: Profound fatigue unresponsive to rest, cognitive impairment ("brain fog"), memory loss, confusion, muscle and joint pain, sensitivity to light, static shocks, vertigo, metallic taste, digestive dysfunction
• What's happening: Mycotoxins bind to cell surface receptors and trigger continuous innate immune activation without adaptive immune clearance. Pro-inflammatory cytokines (TGF-beta, MMP-9, C4a) remain chronically elevated. The blood-brain barrier becomes permeable to inflammatory mediators, causing neurological symptoms
• Diagnosis: Specific blood markers (C4a, TGF-beta-1, MMP-9, VEGF, VIP, MSH), Visual Contrast Sensitivity testing, HLA-DR genetic testing
• Treatment: Removal from exposure (first and most critical step), binders (cholestyramine, activated charcoal), nasal antifungals, and in some cases intravenous immunoglobulin therapy
• Prognosis: Variable. Some patients recover significantly after removal from exposure and treatment. Others have persistent symptoms requiring ongoing management. Early intervention is the strongest predictor of good outcome

The Species Living In Your Air Conditioner

Multiple clinical audits of air conditioner internal surfaces have identified the following organisms present in units that have not been professionally cleaned in 12+ months:

Why This Pattern Is Underdiagnosed

There are several structural reasons why mould-mediated respiratory disease from air conditioning exposure frequently goes unrecognised by the medical system:

1. Temporal delay. The progression from Stage 1 to Stage 3 takes months to years. By the time a patient presents with significant symptoms, the original cause is long disconnected from the current complaint.
2. Nonspecific presentation. Stage 1 and early Stage 2 symptoms are identical to viral illness, seasonal allergy, or "just getting older."
3. The exposure is invisible. The mould is inside the air conditioner, behind the louvers. The patient cannot see it. The GP cannot see it. The connection is never made.
4. No routine environmental history. GPs are not trained to ask "When was your air conditioner last professionally cleaned?" as part of a respiratory workup.
5. Attribution to other causes. Respiratory symptoms get attributed to smoking history, occupational dust exposure, or "post-viral cough" — all of which may be present simultaneously, obscuring the mould contribution.

What The Evidence Shows

The scientific literature on indoor mould and respiratory health is extensive and consistent:

• A 2004 landmark study by the Institute of Medicine (IOM) concluded: "There is sufficient evidence of an association between indoor mould exposure and upper respiratory tract symptoms, cough, wheeze, and asthma symptoms in sensitised persons." This finding has been strengthened, not challenged, by subsequent research.
• The World Health Organisation's 2009 guidelines on indoor air quality identified mould and dampness as consistent, statistically significant risk factors for respiratory disease, noting that "exposure to microbial contaminants is clinically associated with respiratory symptoms, allergies, asthma, and immunological reactions."
• A 2007 meta-analysis published in Indoor Air found that building dampness and mould were associated with approximately 30-50% increases in a variety of respiratory and asthma-related health outcomes.
• In 2011, a review in the Journal of Allergy and Clinical Immunology documented that indoor mould exposure was associated with the development of asthma in children, exacerbation of existing asthma, and allergic rhinitis.
• Multiple case studies in respiratory journals have documented ABPA secondary to contaminated household air conditioning systems, with clinical improvement following source removal.

The Only Fix That Works

Filters catch 20% of airborne particles. Antimicrobial sprays treat visible surfaces. Neither addresses the core problem: the established mould colony inside the unit that continuously releases spores into the air you breathe.

The only intervention that eliminates the source is a complete internal deep clean — disassembly of the unit, chemical treatment of every internal surface, high-pressure flushing of the coils and drain pan, and sanitisation of the fan barrel. This is not a filter change. This is not a surface wipe. This is a full decontamination of the biological reservoir inside your air conditioner.

For most split systems, this takes 90 minutes and costs $250. It should be done every 12 months for a typical Central Coast home — more frequently if you have pets, live near the coast (salt air accelerates corrosion and mould growth), or have household members with asthma or allergies.

Book a Deep Clean — 0432 055 804